Literature DB >> 2170517

Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic.

F G Dunn1, J McLenachan, C G Isles, I Brown, H J Dargie, A F Lever, A R Lorimer, G D Murray, S D Pringle, J W Robertson.   

Abstract

Three thousand seven hundred and eighty-three patients with non-malignant hypertension attending the Glasgow Blood Pressure Clinic between 1968 and 1983 were followed prospectively for an average of 6.5 years. Left ventricular hypertrophy (LVH) was present at the outset in 34.5% of the men, and 12.8% had ST-T changes. The corresponding figures for women were 21.5% and 8.8%. The prevalence of LVH increased with the severity of hypertension and was higher for a given blood pressure level in men than in women. All-cause age-adjusted mortality, expressed as deaths per 1000 patient-years, was 27.6 for men with normal electrocardiographs, 43.2 for men with LVH only (P less than 0.001) and 56.9 for men with LVH and ST-T changes (P less than 0.001). Similar trends were seen in women. The excess risk associated with LVH, with or without ST-T changes, could not be explained by age, increased blood pressure at referral to the clinic, or smoking habit, when these factors were considered either separately or in combination (regression analysis). Thus, our study demonstrates that LVH, with or without ST-T changes is an independent risk factor for mortality in hypertensive patients.

Entities:  

Mesh:

Year:  1990        PMID: 2170517     DOI: 10.1097/00004872-199008000-00012

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  16 in total

Review 1.  Evidence based management of hypertension. Cardiovascular risk factors and their effects on the decision to treat hypertension: evidence based review.

Authors:  R Padwal; S E Straus; F A McAlister
Journal:  BMJ       Date:  2001-04-21

2.  Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; Y Nikitin; J T Salonen; P C Elwood; S Malyutina; A Freire de Concalves; J Sivenius; A Di Carlo; P Lagiou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

Review 3.  Role of ACE inhibitors in hypertension with left ventricular hypertrophy.

Authors:  A M Richards; M G Nicholls; I G Crozier
Journal:  Br Heart J       Date:  1994-09

Review 4.  Hypertension, left ventricular hypertrophy, and sudden death.

Authors:  Lwin Lwin Tin; D Gareth Beevers; Gregory Y H Lip
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

5.  Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme.

Authors:  N M Hawkins; D Wang; J J V McMurray; M A Pfeffer; K Swedberg; C B Granger; S Yusuf; S J Pocock; J Ostergren; E L Michelson; F G Dunn
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

6.  Relationship of Hypertension to Coronary Atherosclerosis and Cardiac Events in Patients With Coronary Computed Tomographic Angiography.

Authors:  Rine Nakanishi; Lohendran Baskaran; Heidi Gransar; Matthew J Budoff; Stephan Achenbach; Mouaz Al-Mallah; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Augustin DeLago; Martin Hadamitzky; Joerg Hausleiter; Ricardo Cury; Gudrun Feuchtner; Yong-Jin Kim; Jonathon Leipsic; Philipp A Kaufmann; Erica Maffei; Gilbert Raff; Leslee J Shaw; Todd C Villines; Allison Dunning; Hugo Marques; Gianluca Pontone; Daniele Andreini; Ronen Rubinshtein; Jeroen Bax; Erica Jones; Niree Hindoyan; Millie Gomez; Fay Y Lin; James K Min; Daniel S Berman
Journal:  Hypertension       Date:  2017-06-12       Impact factor: 10.190

7.  Symptomatic and silent myocardial ischaemia in hypertensive patients with left ventricular hypertrophy.

Authors:  S D Pringle; F G Dunn; A C Tweddel; W Martin; P W Macfarlane; J H McKillop; A R Lorimer; S M Cobbe
Journal:  Br Heart J       Date:  1992-05

Review 8.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

Authors:  Daniel Pewsner; Peter Jüni; Matthias Egger; Markus Battaglia; Johan Sundström; Lucas M Bachmann
Journal:  BMJ       Date:  2007-08-28

9.  Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project.

Authors:  U Lindblad; L Råstam; L Rydén; J Ranstam; S O Isacsson; G Berglund
Journal:  BMJ       Date:  1994-03-12

10.  Cardiovascular Therapeutic Potential of the Redox Siblings, Nitric Oxide (NO•) and Nitroxyl (HNO), in the Setting of Reactive Oxygen Species Dysregulation.

Authors:  Barbara K Kemp-Harper; Anida Velagic; Nazareno Paolocci; John D Horowitz; Rebecca H Ritchie
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.